Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Neurocrine Biosciences Inc.
About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas. Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa, and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights.
Find out what a historical investment in Neurocrine Biosciences Inc. would be worth today using our NBIX stock calculator.
Market Capitalisation
$15.93B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.31M
High today
$159.23
Low today
$155.50
Open price
$158.22
52-week high
$162.39
52-week low
$117.40
Ready to start your investing journey with Stake?
Open an accountHow do I buy NBIX shares in Australia?
Buying NBIX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Neurocrine Biosciences Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NBIX
What is the ticker symbol of Neurocrine Biosciences Inc.?
The ticker symbol for Neurocrine Biosciences Inc. is NBIX.
How much is one share of NBIX?
One share of NBIX is valued at $158.30 as of 16 May 2026.
What is the market capitalisation of Neurocrine Biosciences Inc. NBIX?
As of 16 May 2026 Neurocrine Biosciences Inc. has a market cap of $15.93B.
What is the P/E ratio of NBIX?
The Price to Earnings ratio of NBIX is 24.47.
What is the Earnings Per Share of NBIX?
The Earnings Per Share of NBIX is $6.50.
What is the 52-week high for Neurocrine Biosciences Inc. stock?
The Neurocrine Biosciences Inc. 52-week high stock price is $162.39.
What is the 52-week low for Neurocrine Biosciences Inc. stock?
The Neurocrine Biosciences Inc. 52-week low stock price is $117.40.
Can I buy NBIX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy NBIX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in NBIX on Stake
- Buy NBIX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of NBIX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
NBIX related stocks